Leap Investments’s Guardant Health GH Stock Holding History

Leap Investments’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-26,800	Closed	-$1.71M	–	481
2019 Q3	$1.71M	Buy	+26,800	New	+$2.36M	0.85%	16

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Leap Investments's GH Position: Q4 2019 in Review

Leap Investments sold out of Guardant Health (GH) in Q4 2019, closing a stake of 26,800 shares — an estimated $1.71M sold.

Leap Investments first reported a position in GH in Q3 2019 and held it in 1 quarter. The position peaked at $1.71M in Q3 2019. 268 funds tracked by Wall St. Rank hold GH as of Q4 2019.

Leap Investments reported no remaining Guardant Health position as of Q4 2019 after selling out during the quarter.
Leap Investments sold 26,800 Guardant Health shares in Q4 2019, an estimated $1.71M.
Leap Investments first reported a position in Guardant Health in Q3 2019 and held it in 1 quarter.
Leap Investments's Guardant Health position peaked at $1.71M in Q3 2019.
268 funds tracked by Wall St. Rank held Guardant Health as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.